Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers

Area of Science:

• Genomics
• Cancer Research
• Computational Biology

Background:

• Interpreting noncoding mutations in cancer genomes is challenging.
• Noncoding regions play a crucial role in cancer development.

Purpose of the Study:

• To develop a computational framework for identifying causal noncoding mutations.
• To characterize the full spectrum of noncoding mutations in pediatric cancers.

Main Methods:

• Joint analysis of mutation and gene expression data.
• Identification of single nucleotide variants (SNVs), small insertions/deletions (indels), and structural variants.
• Experimental validation of identified mutations.

Main Results:

• Thousands of putative causal noncoding mutations identified in five pediatric cancers.
• Oncogenic role of CHD4 overexpression via enhancer hijacking validated in B-ALL.
• Exclusivity observed between coding and noncoding mutations affecting the same genes/pathways.
• Integrated mutation profiles defined novel patient subtypes with different clinical outcomes.

Conclusions:

• The developed framework systematically identifies and characterizes noncoding mutations.
• Understanding noncoding mutations is essential for comprehensive cancer genome analysis.
• This strategy can aid in defining new therapeutic strategies and patient stratification.